Acceliant Exhibits Its Capabilities at the DIA India's 7th Annual Conference in Hyderabad

Hyderabad, India, November 09, 2012 --(PR.com)-- Acceliant, a global technology provider of innovative clinical trial solutions, participated in the DIA India's 7th Annual Conference on 'Discovery through Commercialization: Innovative Strategies for Individualized Healthcare' held at Hyderabad International Convention Center, Novotel & HICC Complex, Hyderabad, from November 1 to 4.

The conference was attended by preeminent leaders from healthcare, pharmaceutical, biotechnology, and CROs. Acceliant, also a proud supporter of the conference, showcased its eClinical Suite of products, including the integration of EDC and e-PRO modules that assist clients in addressing their business needs such as time to market, efficiency, and productivity.

Ven Thangaraj, CTO of Acceliant, said, “Participation of Acceliant at the DIA India’s Annual Conference gave us a wonderful opportunity to demonstrate our innovative solutions beneficial for the industry. The event was a huge success with the industry leaders showing their interest in our products and offering insights on their requirements. We would like to express our sincere gratitude to all the attendees for making the conference a grand success for us.”

Santhosh S Nagaraj, Acceliant’s Sales Head - India, said, “DIA’s Annual Conference was a focused event which saw participation from global industry leaders, key decision makers, and market influencers from pharmaceutical industry and CROs. It provided us a unique platform to showcase Acceliant’s integrated, innovative, and future looking solutions, which gained tremendous response from the participants, who expressed their interest in our industry beneficial solutions.”

Acceliant's single e-PRO/EDC system offers a superior solution by allowing all the study data to be readily available, eliminating the integration costs. Acceliant is passionate about healthcare and will continue to focus on leveraging technology to impact the way trials are managed in the industry.

Acceliant eClinical Suite

Acceliant eClinical Suite is competitive in meeting the challenges of today’s dynamic market conditions. The Acceliant eClinical Suite is a pre-eminent offering that continues its 11-year history of providing innovative solutions for the life sciences industry. The Acceliant eClinical Suite is robust, scalable, and flexible. It has been proven by more than 350 Phase I-IV trials, covering all therapeutic areas and medical device trials. Engineered for agility, our service model differentiators enable us to implement and deploy in response to the data, functional, and analytic needs of clinical trials.